The drug, which costs about $11,000 per dose, is given every three weeks for six months.
México Últimas Noticias, México Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
Small Cancer Trial Delivers ‘Unheard-of' Result: Complete Remission for EveryoneA small NYC-led cancer trial has achieved a result reportedly never before seen – the total remission of cancer in all of its patients. To be sure, the trial — led by doctors at Memorial Sloan Kettering and backed by drug maker GlaxoSmithKline — has only completed treatment of 12 patients, with a specific cancer in its early stages and…
Leer más »
Small Rectal Cancer Study Has Remission in Every PatientA small clinical trial with 12 rectal cancer patients found remission in 100% of them, according to a new paper published in The New England Journal of Medicine.
Leer más »
Small study of rectal cancer treatment brings every single patient into remissionEvery single rectal cancer patient with a certain mutation entered remission after receiving the experimental immunotherapy drug in a small clinical trial.
Leer más »
Every patient in this experimental drug trial saw their cancer disappear, researchers sayA small clinical trial conducted by Memorial Sloan Kettering Cancer Center found that every single rectal cancer patient who received an experimental immunotherapy treatment had their cancer go into remission.
Leer más »
Every cancer patient enters remission after drug trial, study revealsA recent drug trial administered at Memorial Sloan Kettering Cancer Center to a handful of cancer patients wiped out the disease in every participant.
Leer más »
A breakthrough drug trial astonished doctors by curing rectal cancer in each patientIn a small-scale experiment being conducted on 12 patients with rectal cancer, researchers tested an immunotherapy drug called dostarlimab and the results astonished scientists with remission in every patient.
Leer más »